News & Events
Updates about Leica Biosystems.
The company’s latest Advanced Staining Solution, BOND-PRIME, is primarily manufactured in Melbourne, Australia MELBOURNE – Leica Biosystems is pleased to announce that the company was a finalist for the 2022 Victorian Manufacturing Hall of Fame Award for Manufacturer of the Year (Large Business).…
SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the…
Solution enables laboratory managers to optimize their tissue processor workflow. NUSSLOCH, GERMANY, FEB 1, 2022. Leica Biosystems is proud to add a new offering to its dualretort tissue processor portfolio: the HistoCore PEGASUS is now available in North American geographies. Building on more than…
CAMBRIDGE, MASS., JANUARY 31, 2022. Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics‘ DKK1 inhibitor, DKN-01 Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (Nasdaq: LPTX), a…
By Chad Salinas, Vice President, AI and Machine Learning Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and…
Leica Biosystems is on track to align its portfolio of instrumentation and consumables with the In Vitro Diagnostics Regulation (IVDR) that comes into effect May of 2022. Internal technical and operations teams, in partnership with Quality & Regulatory Affairs, are taking steps to ensure that…
VISTA, CA –June 17, 2021 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that its Next Generation Aperio GT 450 DX scanner now supports DICOM imaging. Working closely in partnership with Leeds Teaching Hospital NHS as part of the National Pathology Imaging Co-…